Information  X 
Enter a valid email address

EPIC/TIDM matching '0I40'

Date
Time Source
Company
Announcement
07 Sep 2011 12:01 pm GNW Factsheet H. Lundbeck A/S (0I40) Marie-Laure Pochon elected as Lundbeck's new EV...
22 Aug 2011 2:11 pm GNW Factsheet H. Lundbeck A/S (0I40) Announcement of transactions with shares and li...
  9:00 am GNW Factsheet H. Lundbeck A/S (0I40) Launch of Lexapro commenced in Japan
15 Aug 2011 4:15 pm GNW Factsheet H. Lundbeck A/S (0I40) Announcement of transactions with shares and li...
10 Aug 2011 7:01 am GNW Factsheet H. Lundbeck A/S (0I40) First half report 2011 - The solid momentum con...
15 Jun 2011 7:31 am GNW Factsheet H. Lundbeck A/S (0I40) Nalmefene completes clinical phase III programm...
10 Jun 2011 12:05 pm GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck announces that Stig Løkke Pedersen, E...
06 Jun 2011 4:16 pm GNW Factsheet H. Lundbeck A/S (0I40) Announcement of transactions with shares and li...
31 May 2011 4:16 pm GNW Factsheet H. Lundbeck A/S (0I40) Update on Lundbeck's total number of voting rig...
16 May 2011 9:58 am GNW Factsheet H. Lundbeck A/S (0I40) Capital increase in Lundbeck as a result of emp...
  7:31 am GNW Factsheet H. Lundbeck A/S (0I40) Data from four clinical phase III studies of Lu...
13 May 2011 7:53 am GNW Factsheet H. Lundbeck A/S (0I40) Start up of clinical phase III study with Lu AA...
04 May 2011 7:01 am GNW Factsheet H. Lundbeck A/S (0I40) First quarter report 2011 - Lundbeck is off to ...
22 Apr 2011 7:09 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck's partner Mochida receives approval of...
04 Apr 2011 7:30 am GNW Factsheet H. Lundbeck A/S (0I40) Sycrest® roll-out starts with the launch of th...
30 Mar 2011 2:23 pm GNW Factsheet H. Lundbeck A/S (0I40) H. Lundbeck A/S held its Annual General Meeting...
29 Mar 2011 7:31 am GNW Factsheet H. Lundbeck A/S (0I40) A new pharmaceutical candidate enters Lundbeck'...
07 Mar 2011 9:00 am GNW Factsheet H. Lundbeck A/S (0I40) Notice of Annual General Meeting
  8:30 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck's chairman, Per Wold-Olsen, will not b...
04 Mar 2011 7:31 am GNW Factsheet H. Lundbeck A/S (0I40) FDA accepts Lundbeck's submission of the New Dr...
28 Feb 2011 2:08 pm GNW Factsheet H. Lundbeck A/S (0I40) Announcement of transactions with shares and li...
24 Feb 2011 7:04 am GNW Factsheet H. Lundbeck A/S (0I40) Full year report 2010 - Lundbeck delivers at th...
08 Feb 2011 7:31 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck expands its commercial opportunities i...
01 Feb 2011 2:01 pm GNW Factsheet H. Lundbeck A/S (0I40) Annual general meeting at H. Lundbeck A/S
20 Jan 2011 7:30 am GNW Factsheet H. Lundbeck A/S (0I40) The clinical phase III programme commenced on z...
03 Jan 2011 7:01 am GNW Factsheet H. Lundbeck A/S (0I40) First two clinical phase III studies confirm th...
16 Dec 2010 7:03 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck enters into drug discovery collaborati...
14 Dec 2010 8:01 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck to establish a strong, dedicated sales...
04 Dec 2010 5:31 pm GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck reports positive phase III study resul...
23 Nov 2010 8:00 am GNW Factsheet H. Lundbeck A/S (0I40) Financial calendar 2011
04 Nov 2010 3:01 pm GNW Factsheet H. Lundbeck A/S (0I40) Announcement of transactions with shares and li...
03 Nov 2010 7:01 am GNW Factsheet H. Lundbeck A/S (0I40) Third quarter report 2010 -- Continued strong g...
  6:31 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck expects to deliver solid profits durin...
13 Oct 2010 7:31 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck and Genmab enter into a research colla...
12 Oct 2010 10:02 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck and Merck sign exclusive commercialisa...
05 Oct 2010 8:03 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck enters into license agreement with Kyo...
15 Sep 2010 10:10 am GNW Factsheet H. Lundbeck A/S (0I40) Escitalopram filed in Japan
09 Sep 2010 2:01 pm GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck wins Federal Trade Commission case in ...
13 Aug 2010 7:01 am GNW Factsheet H. Lundbeck A/S (0I40) First half report 2010 - Lundbeck reports stron...
05 Aug 2010 2:26 pm GNW Factsheet H. Lundbeck A/S (0I40) TEMPO study further demonstrates the benefits o...
27 May 2010 7:31 am GNW Factsheet H. Lundbeck A/S (0I40) First patients recruited in the extended phase ...
25 May 2010 7:31 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck will submit an NDA for clobazam for pa...
17 May 2010 7:31 am GNW Factsheet H. Lundbeck A/S (0I40) Positive pivotal results on escitalopram in Jap...
10 May 2010 9:01 am GNW Factsheet H. Lundbeck A/S (0I40) Announcement of transactions with shares and li...
06 May 2010 7:03 am GNW Factsheet H. Lundbeck A/S (0I40) First Quarter Report 2010 - Lundbeck delivers s...
22 Apr 2010 1:26 pm GNW Factsheet H. Lundbeck A/S (0I40) H. Lundbeck A/S held its Annual General Meeting...
16 Apr 2010 1:00 pm GNW Factsheet H. Lundbeck A/S (0I40) Update on legal proceedings
  1:00 pm GNW Factsheet H. Lundbeck A/S (0I40) Opdatering vedrørende sagsanlæg
06 Apr 2010 9:01 am GNW Factsheet H. Lundbeck A/S (0I40) Nyt stof til behandling af Parkinsons sygdom - ...
  9:00 am GNW Factsheet H. Lundbeck A/S (0I40) Novel agent for treatment of Parkinson's diseas...
26 Mar 2010 8:04 am GNW Factsheet H. Lundbeck A/S (0I40) Notice of the annual general meeting
  8:04 am GNW Factsheet H. Lundbeck A/S (0I40) Indkaldelse til ordinær generalforsamling
16 Mar 2010 7:32 am GNW Factsheet H. Lundbeck A/S (0I40) Desmoteplase enters clinical phase II in Japan ...
  7:32 am GNW Factsheet H. Lundbeck A/S (0I40) Desmoteplase overgår til klinisk fase II i Jap...
04 Mar 2010 7:02 am GNW Factsheet H. Lundbeck A/S (0I40) Fourth quarter and full year report 2009 - Lund...
  7:02 am GNW Factsheet H. Lundbeck A/S (0I40) Rapport for 4. kvartal og helår 2009 Lundbeck ...
03 Mar 2010 7:31 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck and Takeda finalise plans to initiate ...
  7:31 am GNW Factsheet H. Lundbeck A/S (0I40) Lundbeck og Takeda færdiggør planerne om at i...
25 Feb 2010 9:27 am GNW Factsheet H. Lundbeck A/S (0I40) Data fra en post-hoc analyse af brug af desmote...


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t